Clinical Significance of Serum CYFRA 21-1 in Gastric Cancer
Author Information
Author(s): B Nakata, YS Chung, Y Kato, M Ogawa, Y Ogawa, A Inui, K Maeda, T Sawada, M Sowa
Primary Institution: Osaka City University Medical School
Hypothesis
What is the clinical significance of serum CYFRA 21-1 levels in patients with gastric cancer?
Conclusion
CYFRA 21-1 is a reliable tumor marker for gastric cancer that can predict advanced cases, recurrence, and overall poor prognosis.
Supporting Evidence
- CYFRA 21-1 levels were significantly higher in patients with peritoneal and liver metastases.
- 55.6% of stage IV cases tested positive for CYFRA 21-1.
- Patients with CYFRA 21-1 levels above 5 ng/ml had a significantly poorer prognosis.
- The false-positive rate in benign gastrointestinal disorders was only 2.6%.
- Multivariate analysis indicated that CYFRA 21-1 was an independent prognostic factor.
Takeaway
Doctors can use a blood test for CYFRA 21-1 to help find out how serious someone's stomach cancer is and if it might come back.
Methodology
Sera from 110 gastric cancer patients were analyzed for CYFRA 21-1 levels using a two-step sandwich enzyme immunoassay.
Limitations
The study did not find significant differences in CYFRA 21-1 levels based on histotype, depth of invasion, or vessel invasion.
Participant Demographics
The study included 101 primary and 9 recurrent gastric cancer cases.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website